Taking a broader view of the health care needs of people with chronic kidney disease

Kevan R Polkinghorne and Peter G Kerr
Med J Aust 2022; 216 (3): . || doi: 10.5694/mja2.51387
Published online: 21 February 2022

Older patients may never need kidney replacement therapy, but their other medical conditions require attention

Chronic kidney disease (CKD) is a public health problem worldwide.1 An estimated 1.7 million Australian adults, about 10% of the population, have biomedical signs of CKD,2 but more than half are unaware of their condition. People at particular risk include those over 60 years of age, Aboriginal and Torres Strait Islander people, and people with hypertension, diabetes mellitus, obesity, established cardiovascular disease, a personal history of acute kidney injury or smoking, or a family history of kidney disease. CKD is associated with higher all‐cause mortality, higher rates of cardiovascular disease, and reduced overall quality of life.3,4

  • Monash Medical Centre, Melbourne, VIC


Competing interests:

No relevant disclosures.

  • 1. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020; 395: 709–733.
  • 2. Australian Institute of Health and Welfare. Chronic kidney disease (Cat. no. CDK 16). Updated 15 July 2020.‐7297‐4e7b‐a3e4‐5681c342ed2f/Chronic‐kidney‐disease.pdf.aspx?inline=true (viewed Sept 2021).
  • 3. Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379: 165–180.
  • 4. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296–1305.
  • 5. Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow‐up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659–663.
  • 6. Ravani P, Quinn R, Fiocco M, et al. Association of age with risk of kidney failure in adults with stage IV chronic kidney disease in Canada. JAMA Netw Open 2020; 3: e2017150.
  • 7. Jose MD, Raj R, Jose K, et al. Competing risks of death and kidney failure in a cohort of Australian adults with severe chronic kidney disease. Med J Aust 2022; 216: 140–146
  • 8. Cherney DZ, Repetto E, Wheeler DC, et al. Impact of cardio‐renal‐metabolic comorbidities on cardiovascular outcomes and mortality in type 2 diabetes mellitus. Am J Nephrol 2020; 51: 74–82.
  • 9. Australia and New Zealand Dialysis and Transplant Registry. 42nd report, chapter 3: Mortality in end stage kidney disease. Adelaide: ANZDATA, 2019.‐content/uploads/2019/09/c03_mortality_2018_ar_2019_v1.0_20191202.pdf (viewed Dec 2021).
  • 10. Foote C, Kotwal S, Gallagher M, et al. Survival outcomes of supportive care versus dialysis therapies for elderly patients with end‐stage kidney disease: a systematic review and meta‐analysis. Nephrology 2016; 21: 241–253.
  • 11. Kidney Health Australia. Chronic kidney disease (CKD) management in primary care. 4th edition. Melbourne: Kidney Health Australia, 2020.‐professionals/ckd‐management‐handbook (viewed Sept 2021).


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.